Showing results (71-80 of 100) with videos related to
Sort By:
Pageof 10
Cancer Immunology, Immunotherapy : CII|April 28, 2023
Phase I study of MSB2311, a novel pH-dependent anti-PD-L1 monoclonal antibody, treating patients with advanced solid tumors and lymphomaQi Zhang, Jian Zhang, Haijun Zhong, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 23, 2020
Efficacy, Safety, and Biomarkers of Toripalimab in Patients with Recurrent or Metastatic Neuroendocrine Neoplasms: A Multiple-Center Phase Ib TrialMing Lu, Panpan Zhang, Yanqiao Zhang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2021
Early Interdisciplinary Supportive Care in Patients With Previously Untreated Metastatic Esophagogastric Cancer: A Phase III Randomized Controlled TrialZhihao Lu, Yu Fang, Chang Liu, et al.Frontiers in Immunology|September 26, 2022
Serological biomarkers predict immune-related adverse events and clinical benefit in patients with advanced gastrointestinal cancersYanni Wang, Jianling Zou, Yun Li, et al.Cancer Biology & Medicine|September 27, 2021
Alterations in DNA damage response and repair genes as potential biomarkers for immune checkpoint blockade in gastrointestinal cancerYujiao Wang, Xi Jiao, Shuang Li, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2024
Safety and Efficacy of CT041 in Patients With Refractory Metastatic Pancreatic Cancer: A Pooled Analysis of Two Early-Phase TrialsChangsong Qi, Panpan Zhang, Chang Liu, et al.Cancer Letters|June 14, 2021
Dysregulated KRAS gene-signaling axis and abnormal chromatin remodeling drive therapeutic resistance in heterogeneous-sized circulating tumor cells in gastric cancer patientsYang Chen, Yanyan Li, Changsong Qi, et al.Genome Medicine|November 4, 2021
Germline HLA-B evolutionary divergence influences the efficacy of immune checkpoint blockade therapy in gastrointestinal cancerZhihao Lu, Huan Chen, Xi Jiao, et al.The Oncologist|January 25, 2014
The multicenter, phase II prospective study of paclitaxel plus capecitabine as first-line chemotherapy in advanced gastric carcinomaJifang Gong, Bing Hu, Xiaotian Zhang, et al.Journal for Immunotherapy of Cancer|August 15, 2020
Prediction of immune checkpoint inhibition with immune oncology-related gene expression in gastrointestinal cancer using a machine learning classifierZhihao Lu, Huan Chen, Xi Jiao, et al.Pageof 10